3 completed, 2 unknown. 3 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Unknown 2, Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Institut de la Macula y la Retina: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Response to Supplementation With Postbiotics in Patients With Macular Degeneration. Postbotics and Vitamins, Vitamins - AMD, Soft Drusen | Not applicable | Unknown | Institut de la Macula y la Retina | 48 | 2020-12-02 | 2021-09-24 |
| Oral Postbiotics in Patients With Macular Atrophy postbiotics (IGENH35.3A), vitamins (AREDS formulation and recommended daily dose) - Geographic Atrophy, Age-Related Macular Degeneration | Not applicable | Unknown | Institut de la Macula y la Retina | 10 | 2020-12-01 | 2022-06-24 |
| Micropulse Laser for Geographic Atrophy Micropulse - Geographic Atrophy, Age-related Macular Degeneration | Not applicable | Completed | Institut de la Macula y la Retina | 11 | 2012-08-01 | 2019-09-18 |
| FUSION Regimen: Combined Pro re Nata and Fixed Regimen Ranibizumab in Exudative Age-related Macular Degeneration Ranibizumab - Exudative Age-related Macular Degeneration | Phase 4 | Completed | Institut de la Macula y la Retina | 17 | 2010-11-01 | 2015-03-24 |
| Evolution and Risk Factors Associated With Geographic Atrophy Progression Geographic Atrophy | Completed | Institut de la Macula y la Retina | 96 | 2009-12-01 | 2015-03-24 |
Geographic Atrophy (3) · Macular Degeneration (2)
Vitamins (2) · Ranibizumab (1)
Spain (5)
Jordi M Mones, MD (1) · Jordi Mones, MD, PhD (1)
PMID 22033626, PMID 22440276, PMID 22527314, PMID 23290986, PMID 25406275